A detailed history of Brooktree Capital Management transactions in Pfizer Inc stock. As of the latest transaction made, Brooktree Capital Management holds 113,994 shares of PFE stock, worth $3.13 Million. This represents 2.74% of its overall portfolio holdings.

Number of Shares
113,994
Previous 112,678 1.17%
Holding current value
$3.13 Million
Previous $3.15 Million 4.63%
% of portfolio
2.74%
Previous 2.72%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$27.7 - $31.39 $36,453 - $41,309
1,316 Added 1.17%
113,994 $3.3 Million
Q2 2024

Aug 05, 2024

SELL
$25.26 - $29.6 $216,579 - $253,790
-8,574 Reduced 7.07%
112,678 $3.15 Million
Q1 2024

May 06, 2024

BUY
$25.89 - $29.73 $158,369 - $181,858
6,117 Added 5.31%
121,252 $3.36 Million
Q4 2023

Feb 05, 2024

SELL
$26.13 - $33.94 $258,086 - $335,225
-9,877 Reduced 7.9%
115,135 $3.31 Million
Q3 2023

Nov 06, 2023

BUY
$32.09 - $37.51 $116,807 - $136,536
3,640 Added 3.0%
125,012 $4.15 Million
Q2 2023

Aug 08, 2023

SELL
$36.12 - $41.79 $152,715 - $176,688
-4,228 Reduced 3.37%
121,372 $4.45 Million
Q1 2023

May 08, 2023

SELL
$39.39 - $51.28 $65,348 - $85,073
-1,659 Reduced 1.3%
125,600 $5.12 Million
Q4 2022

Feb 07, 2023

SELL
$41.75 - $54.5 $106,754 - $139,356
-2,557 Reduced 1.97%
127,259 $6.52 Million
Q3 2022

Nov 07, 2022

BUY
$43.76 - $53.42 $247,244 - $301,823
5,650 Added 4.55%
129,816 $5.68 Million
Q2 2022

Aug 08, 2022

BUY
$46.53 - $55.17 $121,955 - $144,600
2,621 Added 2.16%
124,166 $6.51 Million
Q1 2022

May 09, 2022

BUY
$45.75 - $56.69 $385,764 - $478,010
8,432 Added 7.45%
121,545 $6.29 Million
Q4 2021

Feb 07, 2022

SELL
$41.32 - $61.25 $49,831 - $73,867
-1,206 Reduced 1.05%
113,113 $6.68 Million
Q3 2021

Nov 09, 2021

BUY
$39.25 - $50.42 $90,353 - $116,066
2,302 Added 2.06%
114,319 $4.92 Million
Q2 2021

Aug 09, 2021

BUY
$35.91 - $40.68 $622,966 - $705,716
17,348 Added 18.32%
112,017 $4.39 Million
Q1 2021

May 03, 2021

BUY
$33.49 - $37.77 $65,807 - $74,218
1,965 Added 2.12%
94,669 $3.43 Million
Q4 2020

Feb 03, 2021

SELL
$33.47 - $42.56 $35,009 - $44,517
-1,046 Reduced 1.12%
92,704 $3.41 Million
Q3 2020

Nov 09, 2020

BUY
$31.75 - $37.25 $132,207 - $155,109
4,164 Added 4.65%
93,750 $3.44 Million
Q2 2020

Aug 03, 2020

BUY
$30.12 - $36.54 $47,348 - $57,440
1,572 Added 1.79%
89,586 $2.93 Million
Q1 2020

May 06, 2020

BUY
$27.03 - $38.62 $428,912 - $612,822
15,868 Added 21.99%
88,014 $2.87 Million
Q4 2019

Feb 26, 2020

BUY
$32.92 - $37.36 $2.38 Million - $2.7 Million
72,146 New
72,146 $2.83 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $154B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Brooktree Capital Management Portfolio

Follow Brooktree Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brooktree Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Brooktree Capital Management with notifications on news.